X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2874110/0/en/60-Degrees-Pharmaceuticals-Receives-FDA-Comments-on-Tafenoquine-Babesiosis-Clinical-Trial-Protocol-No-Material-Changes-Required.html
https://www.globenewswire.com/news-release/2024/04/03/2856843/0/en/60-Degrees-Pharmaceuticals-to-Sponsor-Pilot-Study-of-Tafenoquine-for-Treatment-of-Canine-Babesiosis.html
https://www.globenewswire.com//news-release/2024/03/14/2846199/0/en/60-Degrees-Pharmaceuticals-Announces-Communication-from-the-FDA-of-Intention-to-Respond-to-Tafenoquine-Babesiosis-Trial-Protocol-Submission-in-April-2024.html
https://www.globenewswire.com//news-release/2024/02/20/2831741/0/en/60-Degrees-Pharmaceuticals-to-Sponsor-Pre-Clinical-Studies-of-Tafenoquine-Use-in-Candida-spp-Including-Candida-auris.html
https://www.globenewswire.com//news-release/2024/02/08/2825942/0/en/60-Degrees-Pharmaceuticals-Appoints-Kristen-Landon-as-Chief-Commercial-Officer.html
https://www.globenewswire.com/news-release/2024/01/31/2821435/0/en/60-Degrees-Pharmaceuticals-Announces-Closing-of-2-4-Million-Public-Offering.html
https://www.prnewswire.com/news-releases/wallachbeth-capital-announces-pricing-of-60-degrees-pharmaceuticals-2-4-million-public-offering-302048008.html
https://www.globenewswire.com/news-release/2024/01/30/2820047/0/en/60-Degrees-Pharmaceuticals-Announces-Pricing-of-2-4-Million-Public-Offering.html
https://www.globenewswire.com//news-release/2024/01/22/2812966/0/en/60-Degrees-Pharma-Plans-Pivotal-Babesiosis-Study-with-Tafenoquine-Following-Jan-17-FDA-Meeting.html
https://www.globenewswire.com//news-release/2024/01/16/2809791/0/en/60-Degrees-Pharma-Regains-Compliance-with-Nasdaq-Listing-Requirements.html
Market Place
Share 
